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Abstract 
Traditionally, the collaboration between university and the industry evolved associated to a kind 
of specialization with university focusing on basic research, whilst the industry mostly 
performing applied research, depicting what is usually called the ‘linear model’ of innovation. 
Recently, some other forms of collaboration emerged, characterized by more informal and 
interactive relationships between academia and industry, with corporate research and 
researchers assuming a more proactive position in the process. 
At the scientific level, the vast majority of literature highlights and analyses the dependence of 
corporate R&D on academic research, being rather unexplored the role that corporate R&D 
might have in scientific outcomes of public R&D organizations. Thus, the aim of the present 
dissertation was to analyse, resorting to a case study methodology, how corporate R&D 
activities impacted on the research performance of a science based organization.  
The analysis of the case study evidenced that indeed corporate (Coimbra Genomics) R&D 
greatly influenced IPATIMUP’s performance in terms of procedures, learning opportunities and 
capabilities to promote more and better innovative research. Several critical factors have 
mediated the relation between corporate R&D and the research performance of IPATIMUP. In 
particular, knowledge proximity existent between corporate and academic players, based on 
previous shared professional experiences, enhanced trust and therefore facilitated the process of 
establishment and development of the project and overcame obstacles related to geographical 
distance (Porto-Coimbra-China). In the present case study no evidence existed that the 
composition of researchers’ age or gender was crucial to the development of the project. In 
contrast, the combination in a single team of individuals with distinct expertise - knowledge of 
life sciences and basic research by IPATIMUP’s researchers and the technological expertise 
associated to more applied research by firm’s collaborators - was critical for the outputs of the 
project, namely the development of a new product.  
These findings suggest that policy makers, while seeking to protect the autonomy and freedom 
of academic researchers, should place greater emphasis on creating effective policies to promote 
university – industry cooperation networks, particularly with R&D producing corporations. In 
times of economic recession and state budget constraints allocated to public R&D, U-I 
collaborations might allow public research institutes/ university to obtain additional financing 
for basic and applied research as well as advanced training. 
Keywords: Innovation; Corporate R&D; University – Industry collaboration; Research 
Performance 
JEL-Codes: O31; O32; O34; O38 
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1. Introduction 
Collaboration between University and the Industry plays a crucial role in the 
development of science and technology (Motoyama, 2013). Traditionally, this 
cooperation evolved associated to some kind of specialization with the university 
focusing (more) on basic research, which aims at generating (new) knowledge 
(Motoyama, 2013), whereas the industry mostly performing applied research seeking to 
commercialize research and technology outcomes (Schartinger, 2002), depicting what is 
usually called the ‘linear model’ of innovation (Guan and Zhao, 2012).  
Recently, some other forms of collaboration emerged, characterized by more informal 
and interactive relationships between academia and the industry, with corporate 
research and researchers assuming a relevant and more proactive position in the process 
of University-Industry (U-I) interaction (Guan and Zhao, 2012; Perkmann et al., 2012; 
Motoyama, 2013). These interactions take multiple forms, with interaction channels 
ranging from inter-organizational relationships (e.g. collaborative research, contract 
research or consulting) to spin-off companies and IP transfer including patenting and 
licensing (D’Este and Perkmann, 2011; King et al., 2011).   
Although extant literature claim that U-I links are characterized by an interactive and 
win-win relations, the vast majority of studies (e.g., Mansfield, 1990; Cohen et al., 
2002; Furman and MacGarvie, 2009; Freitas et al., 2012; Guan and Zhao, 2012; 
Perkmann et al., 2012) highlighted and analysed the (supposedly high) dependence of 
corporate research and innovation on academic research, implicitly assuming a rather 
passive role of corporate R&D.  
It is therefore rather unexplored the role that corporate R&D might have, and how that 
relation happens and evolves, in fostering the scientific outcomes public R&D 
organizations. In other words, it remains scientifically unexplored how corporate R&D 
activities might influence public science/academia. This topic has been recently 
addressed by Coccia (2014) who analysed how new technological paradigms in 
medicine (that results of academic research), driven by cell and molecular biology, 
impacted on corporate R&D [the pharmaceutical industry] in order to support and 
accelerate the drug discovery process. However, this study does not analyse how 
corporate R&D and/or corporate’s needs may be impacting on R&D academic 
performance. Thus, the present work aims to analyse, through a case study 
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methodology, this unexplored research question.  
The dissertation is structured as follows. Section 2 reviews the main relevant literature. 
First it reviews the main definitions of corporate R&D. Second, it examines the main 
research topics within literature of corporate R&D in order to provide a context for the 
study. Third, it analyses the determinants of university/science – industry collaboration 
and a proposal framework of analysis. Section 3 discusses the adequate methodology 
for the research question, presents a brief description of IPATIMUP as a pertinent case 
study, describes the information gathering process, and makes a description of the 
project under study. Section 4 analyses the results of interviews according to the 
theoretical framework. Section 5 presents the main conclusions of the study and 
discusses the implications for public policy authorities and the limitations of the study 
and avenues for future research.    
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2. Literature review the impact of corporate R&D on science performance 
2.1. Definitions of corporate R&D 
Research and Development (R&D) is understood as an important element in an 
economy’s capacity to innovate (Tunzelmann et al., 2010) and has become a critical 
element for firms to ensure economic performance and their survival in the market 
(Cefis, 2010). Traditionally, Research and Development activities have been classified 
as basic research that has been competence of the public sector (Public R&D) and 
applied research that has been seen as the competence of industry (Corporate/Industry 
R&D) (Cox and Gagliardi, 2009). 
Lin et al. (2010: 51) define ‘corporate R&D’ as “... a process via which firms generate 
new products and/ or new processes which can be commercialized afterwards...”.  
Cefis (2010) argues that ‘corporate R&D’ is the capability to exploit new ideas and then 
to generate new products and processes, whereas other authors (e.g, Moncada-Paternò-
Castello, 2010; Hara and Shimizu, 2011; Haak and Wu, 2013) consider ‘corporate 
R&D’ as characterized by knowledge creation and increases in a firm’s ability to 
explore external resources that involve radical projects based on new technologies.  
Although the main dimension of R&D activities in firms is the applied research (see 
Table 1), Hara and Shimizu (2011) and Haak and Wu (2013) highlight the relevance of 
basic research and the role of doctoral scientists in the knowledge creation by firms.  
Table 1: Definitions of corporate R&D 
Study Definition Key dimensions 
Type of R&D 
activities 
Lin et al. (2010)  
"R&D is a process via which firms generate 
new products and/or new processes which 
can be commercialized afterwards (either 
by the firms themselves or by licensing the 
R&D to other parties)." 
 Firm; new products; new 
processes 
Applied 
Research 
Cefis (2010) 
Capability to exploit new ideas and 
generate new products and processes 
Firm; new products and 
processes 
Applied 
Research 
Moncada-Paternò-
Castello (2010) 
 Capability to generate and acquire new 
technology 
Firm; new technology 
Applied 
Research 
Haak and Wu  
(2013) 
Corporate R&D is usually associated with 
long-term oriented, innovative, radical 
projects based on new technologies  
Firm; new technologies Basic Research 
Hara and Shimizu 
(2011) 
Knowledge creation and enhances a firm’s 
ability to assimilate and exploit external 
resources 
Firm; knowledge creation Basic Research 
Source: own elaboration. 
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This type of R&D activities can be influenced by the sector of activity (Hara and 
Shimizu, 2011). Specifically, in sectors like pharmaceutical or biotechnologies, the 
basic research can be more frequent (Hara and Shimizu, 2011) while in sectors like 
electronics or ICT, the applied research plays a more important role (Lin et al., 2010). 
In the context of the present work, we follow the same line of thought as Lin et al. 
(2010) considering corporate R&D as a process by which firms generate new 
knowledge, new products and new processes which can be disseminate for other parties. 
2.2. Main research topics within the literature of corporate R&D 
In last years the topic of corporate R&D has been the subject of wide debate and 
discussion in the literature. Through an extensive search on the bibliographical database 
Sci Verse Scopus using ‘corporate R&D’ as a search keyword, we obtained 125 
articles.
1
 By analyzing all papers’ abstracts we identified the main topics that each study 
have focused. These included by decreasing order of the amount of papers published 
(cf. Table 2): the determinants of R&D investment; the internationalization of R&D 
activities; collaboration between academia and industry; the impact of corporate R&D 
on firm’s performance; and the impact of R&D subsidies on private R&D. 
About 21% of all the studies published on corporate R&D (indexed in Scopus) focused 
on understanding the determinants of corporate R&D investments. The main 
determinants found in the literature includes: opportunities provided by the scientific 
sector (Abdelmoula and Etienne, 2010; Moncada-Paternò-Castello, 2010), spillovers 
(Abdelmoula and Etienne, 2010; Moncada-Paternò-Castello, 2010), market structure 
(Lin et al., 2010; Abdelmoula and Etienne, 2010; Moncada-Paternò-Castello, 2010), 
firm’s characteristics (e.g., firm’s age and size) (Etienne, 2010; Lin et al., 2010; 
Moncada-Paternò-Castello, 2010; Hirschey et al., 2012; Rhee and Yoo, 2013; Saad and 
Zantout, 2014) appropriability (Lin et al., 2010; Abdelmoula and Etienne, 2010; 
Moncada-Paternò-Castello, 2010), profitability (Abdelmoula and Etienne, 2010; 
Hirschey et al., 2012), access to finance (Lin et al., 2010; Moncada-Paternò-Castello, 
2010), incentives (Pereto, 1998; Klassen et al., 2004; Lerner and Wulf, 2007; Lin et al., 
2010; Abdelmoula and Etienne, 2010), corporate governance structure (Dong and Gou, 
2010; Lee, 2012; Rhee and Yoo, 2013), and macroeconomic environments (Klassen et 
al., 2004; Lee, 2012; Cincera et al., 2012).       
                                                          
1
 The reference date for this search is October 11
th
, 2014. 
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Another topic which attracted a reasonable amount of attention is the 
‘internationalization of R&D activities’. This terminology is widely used in the 
literature but some authors have shown preference for the term ‘globalization of R&D’ 
to refer to the same phenomenon. Dachs and Pyka (2010) says that internationalization 
of R&D activities is defined by trans-border technological alliances, share of joint 
scientific publications involving authors from different countries, international mobility 
of researchers and a trans-border financial flows related to science and technology, 
whereas Guimón (2011: 77) define this process as “…the high and increasing share of 
R&D activities that MNE’s are performing through their international network of 
subsidiaries”. The main driving factors and attractors of foreign-located innovation 
activities found in the literature are the market size (Hedge and Hicks, 2008; Dachs and 
Pyka, 2010; Moncada-Paternò-Castello et al. 2011; Aoyama and Parthasarathy, 2012; 
Liang et al., 2014), the high level of scientific and technological capabilities (Reddy, 
1997; Hedge and Hicks, 2008; Dachs and Pyka, 2010; Moncada-Paternò-Castello et al., 
2011; Liang et al., 2014), quality of R&D personnel (Tijssen, 2009; Vivarelli, 2011; 
Wang, 2014), strong IPR protection (Tijssen, 2009; Dachs and Pyka, 2010; Moncada-
Paternò-Castello et al., 2011; Belderbos et al., 2013), and public support of R&D 
activities (Moncada-Paternò-Castello, 2011).   
The impact of corporate R&D on firm’s productivity is addressed by 5% of the studies. 
The positive impact is mainly felt in firms operating in high- and medium-tech sectors; 
corporate R&D tend to have minor productivity impacts in firms from low-tech sectors 
(Graves, 1989; Gassman et al., 2009; Kumbhakar et al., 2012). 
A very small fraction of studies analyze the role of public support on corporate R&D. 
Dumont (2013) and Burger et al. (2013) observed that public support has stimulated 
companies to carry out additional R&D activities and stimulated the spending in 
innovation.  
The topic that is the focus of the present dissertation - university-industry collaboration 
– has attracted a relatively low percentage of studies (13%). Within it, Mansfield (1991) 
observed that approximately 10% of the product and process innovations could not have 
been developed without academic research. Additionally, other authors (e.g., Jaffe, 
1989; Cohen et al., 2002) show that university research has a significant impact on 
corporate patents and enhances new corporate R&D projects. More recently, Furukawa 
and Goto (2006) and Hara and Shimizu (2011) show that industry-based doctoral 
 6 
scientists play an important role in stimulating in-house knowledge creation and 
knowledge diffusion outside the firm’s boundaries. 
From analyzing this stream of the literature it is possible to realize that the vast majority 
of studies focuses on the dependence of corporate research and innovation on academic 
research and less so the other way around. 
Table 2: Main research topics within the literature of corporate R&D  
Topic Description  Main Studies Percent (%) 
Determinants of R&D 
investment 
Main determinants of corporate 
R&D investments by firms 
Pereto (1998); Klassen et al.(2004); 
Lerner and Wulf (2007); Lin et al. 
(2010); Abdelmoula and Etienne (2010); 
Moncada-Paternò-Castello (2010); 
Dong and Gou (2010); Hirschey et al. 
(2012); Lee (2012); Cincera et al. 
(2012); Rhee and Yoo (2013); Saad and 
Zantout (2014) 
21 
 Internationalization of 
R&D activities 
Main driving factors and 
attractors of foreign-located 
innovation activities 
Reddy (1997); Hedge and Hicks (2008); 
Tijssen (2009); Dachs and Pyka (2010); 
Guimón (2011); Moncada-Paternò-
Castello et al. (2011); Aoyama and 
Parthasarathy (2012); Belderbos et al. 
(2013); Liang et al. (2014) 
14 
University – Industry 
Collaboration 
Universities and public research 
institutions are an important 
external resource in corporate 
R&D  
Jaffe (1989); Mansfield (1991); Cohen 
et al. (2002); Furukawa and Goto 
(2006); Hara and Shimizu(2011) 
13 
The impact of corporate 
R&D on firm's 
performance 
The corporate R&D has a 
significant impact on company's 
productivity especially in high 
and medium - tech sectors 
Graves (1989); Gassman et al.(2009); 
Kumbhakar et al. (2012) 
5 
The impact of R&D 
subsidies on private R&D 
Public support can stimulate 
companies spending more in 
innovation 
Dumont (2013); Burger et al. (2013) 3 
Note: the grey cells identify the stream of research within it the present dissertation develops its argument. 
Source: own elaboration. 
2.3. Determinants of University/science – industry collaboration: a proposal for a 
framework of analysis  
University – Industry (U-I) collaboration have emerged as a separate field of research in 
the last few years (Rothaermel et al., 2007). According to the literature, there are two 
main ways through which U-I collaboration might occur: university entrepreneurship 
and academic engagement. University entrepreneurship involves patenting, licensing 
and creating of new firms based on university research outcomes (Rothaermel et al., 
2007), whereas academic engagement is defined as knowledge-related collaborations 
encompassing academic researchers and firms, and usually involve ‘person-to-person’ 
interactions (Perkmann et al., 2012).  
Since the aim of the present dissertation is to analyse how corporate R&D might impact 
on academic research outcomes and given that studies within the topic ‘university 
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entrepreneurship’ do not explicit focus on the linkages between the university and 
firms/corporations, our literature review is mainly addressing studies within the 
‘academic engagement’ stream. 
This latter literature highlights two main aspects: the motivations of academic 
engagement, and the determinants of successful/ research performance of academic 
engagement.  
Theoretically, in an economy geared to innovation and competitiveness in research and 
development (R&D) activities, inter-relationships between the university and private 
enterprises constitute a priority strategy and a tool in knowledge – based economies 
(Olmeda – Gómez et al., 2008). U – I relationships are examples of inter-organizational 
relationships, which can be motivated by a variety of rationales, such as efficiency and 
reciprocity (King et al., 2011). On the one hand, the motivations of academic 
researchers to work with industry are informed by main four rationales: 
complementarities between their academic work and industry engagement (D’Este and 
Perkmann, 2011; King et al., 2011), mobilizing resources that complement public 
research funding (D’Este and Perkmann, 2011; King et al., 2011), acquisition of 
additional resources for research (e.g. accessing laboratory equipment) (Neely et al., 
2011), learning opportunities via novel insights, ideas and techniques that eventually 
result in published scientific research (D’Este and Perkmann, 2011) and employment 
opportunities (Olmeda – Gómez et al, 2008). On the other hand, industry partner’s 
reasons for involvement are based on accessing academic expertise to benefit their 
R&D and/ or product development activities, gaining insights on emerging technologies 
and enhancing their knowledge bases (King et al., 2011), sharing risks and costs (Dalpé, 
2013; Fiaz, 2013), and gaining prestige by forging alliances with reputed universities 
(Olmeda – Gómez et al, 2008). 
In literature, there are determinants that may influence the success of collaboration and 
research performance or serve as barrier to its success (see Table 3). These determinants 
are related to distinct types of factors (individual, organizational and contextual factors) 
and occur through different channels – see Figure 1. 
Indeed, according to literature, the results from academic research can be transferred to 
firms and industries through a variety of channels, including publication of fundamental 
research or inter – institutional co – authorship of research articles (Cohen et al., 2002; 
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Olmeda – Gómez et al., 2008; Teixeira and Mota, 2012; Goel and Goktepe – Hultén, 
2013), collaborative research
2
 (Cohen et al., 2002; Perkmann and Walsh, 2009; D’Este 
and Perkmann, 2011; King et al., 2011; Guan and Zhao, 2012; Perkmann et al, 2012), 
contract research
3
 (Cohen et al., 2002; Perkmann and Walsh, 2009; D’Este and 
Perkmann, 2011; King et al., 2011; Perkmann et al., 2012), consulting
4
 (Cohen et al., 
2002; Perkmann and Walsh, 2008; Perkmann and Walsh, 2009; D’Este and Perkmann, 
2011; King et al., 2011; Perkmann et al., 2012; Goel and Goktepe – Hultén, 2013), 
informal interactions in meetings/ conferences (Fiaz, 2013), personnel mobility (Cohen 
et al., 2002) and, in a more formal way, licensing (Cohen et al., 2002). 
 
Figure 1: Framework of analysis of determinants of University/science – Industry collaboration 
 Source: own elaboration.  
Perkmann and Walsh (2009) established that collaborative forms of interaction, such as 
collaborative research, contract research and consulting, are seen by industry as more 
important and valuable than IP transfer, such as licensing. In same study, the authors 
found that collaborative research with industry results in academic publications while 
this is less true for relationship with more applied objectives, such as contract research 
and consulting. However, consulting facilitates interactive learn which in turn indirectly 
benefits scientific production by generating new ideas and new research projects.  
                                                          
2
 Collaborative research refers to “research jointly pursue by university and industrial partners – 
commonly with public funding (King et al., 2011: 540).  
3
 According to King et al. (2011: 540), contract research is “application – oriented research and 
development activities carried out by university – commissioned and funded by industry”. 
4
 Consulting refers to research or advisory services provided by individual academic researchers to their 
clients (Perkmann and Walsh, 2008). 
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Table 3: Factors influencing the success of collaboration and research performance: a synthesis of the literature 
Study Main Topic Country 
Determinants of relationship 
Research Field Main Conclusions 
Individual Factors 
Organizational 
Factors 
Contextual 
Factors 
Powell et al. (1996) 
Networks of learning as access 
to knowledge 
USA 
Experience; 
Reputation 
Trust; Project 
Management; 
Absorptive 
Capacity 
Industry 
Characteristics 
Biotechnology/ 
Pharmaceutical 
The development of a absorptive capacity and skill at 
managing collaborations as well as the increased 
awareness of new projects and reputation as a valuable 
partner are all benefits to collaboration    
Dalpé (2003) 
Why academic researchers are 
still important players in 
industry 
Canada Reputation 
Project 
Management; 
Absorptive 
Capacity; Trust 
Industry 
Characteristics; 
Geographical 
Proximity 
The capacity of a new firm to get financing is correlated 
with the reputation of researchers, as measured by 
citations to their scientific publications 
Furukawa and Goto 
(2006)  
The role of corporate scientists 
in innovation 
Japan 
Reputation; 
Experience 
  
The existence of corporate scientists is important for 
companies to absorb external knowledge and its crucial 
that they conduct high quality research and have solid 
reputation in the research community 
Lacetera (2009) 
The determinants of a company's 
choice to outsource research 
projects to academic 
organizations 
USA 
 
Department 
quality 
Industry 
Characteristics 
Outsourcing a project to a university allows a firm to 
commit not to terminate or alter a scientifically valuable 
project before completion 
Furman and 
MacGarvie (2009) 
The Importance of academic 
science in the emergence of 
industrial research capabilities 
USA 
  
Geographical 
Proximity 
Firms at early stages of development appear most likely to 
collaborate locally while firms with greater R&D 
capabilities engage in both local and distant collaboration 
Barnes et al. (2006) 
The determinants for an 
effective management of 
collaborative R&D projects 
UK Experience 
Project 
Management 
 
Engineering 
Inexperienced or ineffective project managers had a 
negative impact on collaboration 
Shimizu and Hara 
(2011) 
The role of doctoral scientists in 
corporate R&D 
Japan Doctoral Degree 
  
Doctoral scientists play an important role in stimulating 
in-house knowledge creation and knowledge 
dissemination outside the firm's boundaries 
Thune (2011) 
The potential factors in U-I 
partnerships  
Norway Experience 
Project 
Management; 
Trust 
Geographical 
proximity; Public 
Policies 
Geographical proximity eases communication and that is 
more efficient to collaborate when partners are stimulated 
in the same geographical area 
Melkers and Xiao 
(2012) 
Characteristics of academic 
scientists who are engaged in 
funded research 
USA Gender 
  
In field of electrical engineering, women scientists have a 
higher likelihood to conduct emerging technology research 
while in field of biological science men tend to be more 
likely to be funded in new technologies areas.  
Freitas et al. (2013) 
The role of U-I interactions for 
innovation in mature and 
emergent industries 
Brazil 
  
Industry 
Characteristics 
University research and developments projects with firms 
in emergent industries are less likely to be the result of 
academic initiatives 
Harris and Lyon 
(2013) 
How collaboration is operating 
and approaches to building trust 
in U-I relationships 
UK 
 
Trust 
 
Environmental 
Trust is vital when crossing professional cultural 
boundaries as people are opening themselves to 
vulnerability and risk. 
Jaffe (1989) 
The effects of academic research 
on industry innovation 
USA 
  
Scientific 
Discipline 
 
A significant effect of university research on corporate 
patents is found, particularly in the areas of Drugs and 
Electronics 
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(…) 
Source: own elaboration 
Study Main topic Country 
Determinants of relationship 
Research 
Field 
Main Conclusions 
Individual Factors 
Organizational 
Factors 
Contextual Factors 
Mansfield (1991) 
The effects of academic research 
on industry performance 
USA 
  
Scientific discipline 
 
The contribution of academic research on industry innovation 
has been considerable in industries like drugs and ICT  
Schartinger et al. 
(2002) 
Determinants of knowledge 
interactions 
Austria Experience 
Department 
quality 
Scientific discipline 
 
Technical sciences and R&D intensive manufacturing tend to 
use direct research cooperation more intensively, service 
industries and social sciences rest more on personnel mobility 
and training.  
Cohen et al. (2002) 
The role of public R&D on 
industrial R&D 
USA 
  
Scientific discipline; 
industry characteristics 
 
The impact of public R&D is strong in the drug and medical 
equipment industries and large firms 
Sherwood and Covin 
(2008) 
How factors may affect the 
successful transference of 
technology knowledge between 
partners 
  
Trust 
  
Trust between partners is a significant factor of successful 
knowledge acquisition for tacit knowledge 
Barbolla and 
Corredera (2009) 
Critical factors for success in U-
I partnerships 
Spain Experience 
   
A higher percentage of university research groups taking part 
in successful projects knew their industrial partners 
King et al. (2011) 
How university department 
quality shapes their engagement 
with industry 
UK Reputation 
Department 
quality 
Scientific Discipline; 
Industry characteristics 
 
The relationship between department quality, researcher’s 
reputation and industry involvement differs according to 
disciplinary orientation and firm's size 
Bishop et al. (2011) 
The benefits of U-I 
collaborations 
UK 
 
Department 
quality 
Geographical Proximity 
 
Geographical proximity between partners is significant only 
for benefits associated with direct assistance in problem 
solving and research quality of the university is a critical factor 
for firm's outcomes   
Fuentes and Dutrénit 
(2012) 
The impact of channels of 
interaction on the perceived 
benefits by researchers and firms 
Mexico 
Age; Gender; 
Experience; 
Reputation 
Trust 
Public Policies; Industry 
Characteristics; 
Geographical 
Proximity; Scientific 
Discipline 
 
The main characteristics of researchers that foster long-term 
benefits for firms are related to individual and institutional 
characteristics, such as doctoral degree, field of knowledge, 
research team and the acquisition of public financing for 
research 
Perkmann et al. 
(2012) 
Determinants of academic 
engagement 
 
Experiences; Age; 
Gender; Reputation 
Project 
Management; 
Department 
Quality 
Scientific Discipline; 
Public Policies 
 
Factors like age, gender, experienced researchers, reputation 
and management skills had a positive impact on academic 
engagement 
Lakpetch and 
Lorsuwannarat (2012) 
A model for measuring the 
knowledge transfer effectiveness 
of U-I alliances  
  
Trust; Project 
Management 
Industries 
Characteristics 
 
The influence of cultural differences between university - 
industry partners can be problematic to the alliance projects, so 
a manager should establish teamwork in order to break the 
monoculture  
Fiaz (2013) 
The importance and the role of 
U - I collaboration in economic 
development 
China 
 
Trust 
Public Policies; Industry 
Characteristics  
Proper communication, R&D capacity and R&D tendency are 
the main factors to sustain U-I collaborations  
Goel and Goktepe-
Hultén (2013) 
The effects of personal and 
professional characteristics on 
academic patenting 
German 
Age; Gender; 
doctoral degree 
Group Leader Scientific discipline 
 
Researcher's age, group leadership, doctoral degree and hard 
sciences were more likely to result in patenting 
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Regarding the individual factors that might explain the U-I interactions, Perkmann et al. 
(2012) argue that individuals’ characteristics like experience, reputation, team diversity 
or a doctoral degree (cf. Figure 1), play an important role in predicting academic 
engagement.  
Given that engagement is often seeded by personal contacts, more experienced 
researchers (academic researchers or corporate researchers) are likely to have larger 
networks, enabling them to find potential partners (Perkmann et al., 2012). Perkmann et 
al. (2012) confirm that scientific productivity is generally positively related to 
engagement, i.e, the best and most successful scientists are also those who engage most 
with industrial partners. Moreover, Schartinger et al. (2002) highlight that previous 
knowledge interactions by university departments will expand the contact network 
relevant for knowledge spill-over to industry and thus increase the probability of future 
interactions and Barbolla and Corredera (2009) show that a higher percentage of 
university research groups taking part in successful projects knew their industrial 
partners from previous collaborations. In addition, Barnes et al. (2006) found that 
inexperienced or ineffective project managers had a negative impact on collaboration 
and they affirm that experienced partners are better able to understand the capabilities 
and the limitations of a collaborative venture, and also tend be more flexible. Thune 
(2011) highlights the relevance of academic staff or key persons that take care of the 
practical sides to collaboration, generate activities and function as the point of contact 
between the companies and academia with a business background and a long experience 
in co-operation between firms and universities. This suggests that the past experiences 
of researchers, corporate researchers and academics researchers, constitute an important 
factor to successful outcomes of collaboration.  
King et al. (2011) found that relationship between researcher’ reputation and industry 
involvement differs according to disciplinary orientation. For the technology – oriented 
disciplines, the researchers in the best departments are also those with high industry 
involvement while for the social sciences, they found a negative relationship. In 
contrast, in same study King et al. (2011) found that the most successful researchers are 
able to raise the most resources, which, in turn, enables them to generate even more 
research outputs, so the best researchers are less dependent on working with industry. 
Although the literature only emphasizes the relevance of reputation of academic 
researchers, in same way the reputation of corporate researchers is an important 
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determinant for collaboration. According to Dalpé (2003) the capacity of a new firm to 
get financing is correlated with the reputation of researchers, as measured by citations to 
their scientific publications.  
Another important factor is the team diversity. Some studies show that researchers with 
different ages, different genders and different areas of knowledge in same team work 
can be a stimulus to creativity and that will be profitable for collaboration. Lee et al. 
(2015) examined the influence of shared leadership and diversity on knowledge sharing 
and the subsequent effects on team creativity and they found positive relationships 
between age, gender and knowledge diversity on team creativity. Pitt-Catsouphes et al. 
(2013) demonstrate that age diversity can stimulate and/ or support creative thinking 
and might contribute to innovation at the workplaces. Moreover, Bear and Woolley 
(2011) analyse the role of gender in team collaboration and performance and conclude 
that gender diversity can enhance group processes and affirms be an important factor in 
the production of science.  
Among individual and professional characteristics mentioned above, having a doctoral 
degree also plays a role in U-I collaboration, mainly for corporate R&D. Shimizu and 
Hara (2011) explore both direct and indirect contributions of doctoral corporate 
engineers to R&D by examining their papers and patents and results indicate that these 
scientists achieved a higher average number of papers and patents than non-doctoral 
scientists and they play an important role in promoting corporate R&D by linking 
corporate R&D with university research. Moreover, Goel and Goktepe-Húlten (2013) 
studied the effects of industry interactions on academic patenting, using a survey of 
scientists at a large public research organization in Germany and the study revealed that 
among professional characteristics, having a doctoral degree was more likely to patent. 
They established that “doctoral education provides scientists with a broader research 
perspective that enables them to better see the ‘holes’ in research and identify directions 
that might more likely yield patentable outcomes” (Goel and Goktepe-Húlten, 2013: 
558). In addition, Lam (2007) and Thune (2010) demonstrate that doctoral corporate 
researchers are vital in network configurations and they are seen as “bridge builders” 
between university and industry, and Fuentes and Dutrénit (2012) conclude that 
researchers who have PhD degrees are more likely to have a potential impact on the 
long-term benefits of firms.  
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In terms of organizational factors, a necessary ingredient for a successful U-I 
collaboration is department quality (cf. Figure 1). Schartinger et al. (2002) show that a 
precondition for a field of science at a university to be used as interaction partner by 
industry is the acknowledgement of the department’s expertise. Out of the three main 
activities that universities devote resources to, only research activities result in the 
development of expertise and scientific excellence, which renders knowledge exchange 
profitable for their partners, so in order to reduce risk and costs of knowledge 
interactions, industry tends to look for university departments offering a higher quality 
of research output. Furthermore, King et al. (2011), using a dataset covering all UK 
universities, found that the relationship between department quality and industry 
involvement differs according to disciplinary orientation. Specifically, in technology – 
oriented disciplines department quality is positively related to industry engagement, in 
medical and biological sciences, department quality is positively related to industry 
engagement, particularly when it comes to working with large firms. However, where 
resources requirements play a less important role, such in the social sciences, 
department quality is negatively related to industry engagement. Bishop et al. (2011) 
reveal that is top quality department research of universities that mainly contributes to 
the development of patentable inventions of firms. 
Project management is a key issue in the process. Butcher and Jeffrey (2007) and 
Niesten and Jolink (2015) argue that it is important a focus on establishing common 
expectations and goals, development of a project plan and store alliance management 
knowledge in order to apply this in future collaborations are underlined. Thune (2011) 
studied the success factors in higher education – industry collaboration between four 
regional universities and energy firms in Norway and concluded that project leadership 
is a factor that influences the collaboration climate and having an experienced project 
leader was considered a success factor in all cases.   
Relationships between different types of research organizations (academia and 
industry), with different approaches of actors from different cultures, with varied norms, 
different perspectives, through styles and values result in conflicts (Lakpetch and 
Lorsuwannarat, 2012), particularly with respect to perceptions of the quality of work, 
timing of publishing results and where work is disseminated (Harris and Lyon, 2013). 
So, a manager should establish teamwork in order to break the tension between different 
cultures within alliance partners to become more multifunctional (Lakpetch and 
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Lorsuwannarat, 2012). In this context, there is a need to build a relationship based on 
trust. Harris and Lyon (2013) analysed ten case studies of research collaborations 
related to sustainability and environmental and examined the different professional 
cultures and the process of building trust. Results evidenced that trust is shown to be 
built by having information on others, prior experiences of working together, norms of 
cooperation (helping each other on specific problems and sharing knowledge and 
keeping to agreements and honesty), open communications and sanctions exerted on 
those who might transgress norms of behavior. Moreover, Sherwood and Covin (2008) 
affirm that trust between partners was a significant factor of successful knowledge 
acquisition, mainly for tacit knowledge.   
Dalpé (2003) shows that there are some limitations on collaborations, and the potential 
gain in networking depends on the quality of interactions, which involve a diversity of 
actors with partly conflicting interests. He affirms that relations between actors must be 
based on trust, built by personal interactions and governed by mechanisms of 
coordination that help solve conflicts. 
Another crucial factor for a successful collaboration is the absorptive capacity of 
organizations. According to Powell et al. (1996) and Azagra – Caro et al. (2013), a firm 
with a greater capacity to learn is adept at both internal and external R&D, thus 
enabling it to contribute more to collaboration as well as learn more extensively from 
such participation. Moreover, internal capability and external collaboration are not 
substitutes for one another, but complementary. In other words, inter-organizational 
collaborations are not simply a means to compensate for the lack of internal skills, but a 
firm’s value and ability as a collaborator is related to its internal assets (Dalpé, 2003).    
Finally, contextual factors (see Figure 1) include factors that are instrumental for the 
formation of collaborative relationships. In some of the reviewed studies (e.g. Jaffe 
1989; Mansfield, 1991; Cohen et al., 2002; Schartinger et al., 2002), the determinants 
and motivations for U-I engagement differ across scientific disciplines and sectors of 
economy activity and fields of science engage in different types of interactions. 
Schartinger et al. (2002) analyzed the determinants of knowledge interaction between 
different fields of research and sectors of economy, based on a comprehensive dataset 
on various types of knowledge interactions between university departments and private 
firms in Austria in 1990s. Their results suggest that while technical sciences and R&D 
intensive manufacturing industries tend to use direct research cooperation more 
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intensively, service industries and social and economic sciences rest more on personnel 
mobility and training related interactions. Jaffe (1989), Mansfield (1991) and Cohen et 
al. (2002) show that the impact of public R&D on industry innovation is strong, 
particularly in the areas of drugs, electronics and ICT. 
Additionally, industries characteristics have a relevant role in the U-I process. Freitas et 
al. (2012) explored the role of U-I collaboration for the development of innovation in 
mature and emergent industries in new industrialized countries based on 24 researches 
groups in science and engineering departments in universities and public research 
organizations in Brazil. The authors found that university research and developments 
projects with firms in emergent industries are less likely to be the result of academic 
initiatives and public calls for research projects, or to be wholly financed by major 
public research sponsors than projects with firms in mature industries. In emergent 
industries, the role of students and firm employees is crucial for mediating between 
public research organizations and companies. Furthermore, Powel et al. (1996) studied 
collaborative activities between academia and biotech firms and show that several 
standard organizational characteristics, such as age and size, appear to be ancillary in 
accounting for patterns of collaboration. 
Geographical proximity between partners has been also identified as an important 
condition for U-I collaboration. Thune (2011) and Fuentes and Dutrénit (2012) affirm 
that geographical proximity eases communication, and that it is more efficient to 
collaborate when partners are stimulated in the same geographical area. Additionally, 
Bishop et al. (2011) find that geographical proximity between partners is only 
significant for benefits associated with direct assistance in problem solving, supporting 
the argument that proximity facilitates the exchange of tacit and context-specific 
knowledge. Additionally, Furman and MacGarvie (2009) argue that firms at early stages 
of development appear most likely to collaborate locally while firms with greater R&D 
capabilities engage in both local and distant collaboration.      
Management of university – industry research collaboration is the key to its success. In 
this respect, government can play an essential role in process (see Figure 1). A public 
subsidy for R&D is not only an important financial support for U-I collaboration but 
may also serve as a useful means of promoting trust among collaboration members 
resulting in higher innovation performance (Lee and Park, 2006; Okamuro and 
Nishimura, 2014).  
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3. Methodological considerations 
3.1. Main research question and methodologic options 
The aim of the present research is to analyze how corporate R&D activities impact on 
the research performance of a science based organization in its most diverse 
dimensions, most notably publications and patents.  
Given that we aim at understanding how the U-I collaboration evolves and how 
corporate R&D might impact on public science organization’s outcome, according to 
Yin (2009) such “how” question renders the case study as the preferred methodology. 
This is further supported by the fact that several reviewed studies with similar research 
aims (see Table 4) resorted to case studies as their elected methodology. 
We selected one science based organization related to life sciences field - IPATIMUP
5
- 
because, according to literature (Powell et al., 1996; Furman and MacGarvie, 2009; 
Guan and Zhao, 2012; Coccia, 2014), organizations related with life science are 
characterized by a strong reliance on scientific developments and, therefore involves 
high levels of interaction among universities and firms. 
Table 4: Research question and qualitative methodologies: examples of the literature on U-I links  
Study Research question Actors (#) involved Country Research Field 
Perkmann and 
Walsh (2009) 
The impact of university - industry 
relationships on public research 
University; Firm UK 
Engineering Thune (2011) 
What potential success factors are 
relevant when developing and 
managing higher education - 
business partnerships  
University; Firm Norway 
Freitas et al. 
(2012) 
The role of university - industry 
collaboration for innovation in 
mature and emergent industries 
Firm Brazil 
Motoyama 
(2013) 
How a university collaborates both 
with a large firm and a venture firm 
University; Firm; 
Corporate Research 
Japan Nanotechnology 
Coccia (2014) 
How convergence of scientific 
fields and new technological 
paradigms impact on R&D 
corporate change 
Firm Italy Pharmaceutical 
Source: own elaboration. 
 
3.2. IPATIMUP as a pertinent case study. A brief description 
The IPATIMUP, Institute of Molecular Pathology and Immunology of the University of 
Porto, is a private non-profit association of public utility, founded in 1989 under the 
                                                          
5
 Institute of Molecular Pathology and Immunology of the University of Porto. 
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aegis of the university of Porto and was one of the four first Associated Laboratories 
created, in 2000, by the Portuguese Ministry of Science and Higher Education. 
In terms of research activity, IPATIMUP focuses on the areas of oncology (cancer and 
precancerous lesions of the thyroid, stomach, colon and breast cancer, among others) 
and in populations genetics and forensic. 
According to the 2014 activity report, IPATIMUP reached the number of 169 papers 
published in international indexed journals. Of the 169 articles, 20 were published in 
journals with impact factor (IF) higher than 6; 65 in journals with IF between 3 – 6; and 
59 journals with IF between 1 and 3, being a world – leading institute in scientific 
production.  
To reset the science strategy of IPATIMUP and design of the lines in cancer research 
area for the coming years, it was created, in 2012, a task force involving group leaders 
and senior researchers. This task force listed the most competitive research lines in the 
field of cancer in IPATIMUP, where several research groups were formed (see Table 5). 
Table 5: Research groups of IPATIMUP 
Research Group Aims 
Cancer Biology 
To identify molecular targets involved in the ethiopathogenesis of human cancer 
with potential applications in early diagnosis and specific therapy 
Population Genetics 
To understand the origin and evolution of genetic diversity, their consequences and 
applications  
Glycobiology in Cancer 
To understand molecular mechanisms controlling alterations of glycosylation that are 
important in the process of carcinogenisis and cancer progession  
Genetic Dynamics of 
Cancer cells 
To understand how do genetic mutations arise in tumor cells and how do they spread 
in tumor cells and how do they spread in tumor cell subpopulations; and why do 
these tumor cell subpopulations fluctuate over time and how does this influence, and 
is influenced by clinical events such as therapy and disease progression 
Genetic diversity 
To establish a bridge between hypotheses, methods and results from a theoretical 
approach to neutral human genetic diversity and evolution through time and space, 
integrating this information in clinical and forensic contexts 
Expression Regulation in 
Cancer 
To disclose germline and somatic regulatory mechanisms and molecular circuitries, 
acting to increase gastric cancer susceptibility, and to confer advantageous features 
to cancer cell populations. 
Differentiation and Cancer 
To understand how differentiation shifts predispose and progress to cancer and 
identity novel biomarkers and therapeutic targets to improve diagnostic, prevention, 
patient stratification and treatment of cancers of the gastrointestinal tract. 
Cancer Genetics 
To uncover how epithelial cell - cell and cell - matrix junctions (based on three 
common epithelial - derived cancers - gastric, breast and colorectal) as well as the 
surrounding microenvironment, can influence cancer progession. 
Cancer Drug Resistance 
To translate basic science findings into validation of potentially new molecular 
targets for cancer therapy, using several in vitro models for different cancer types. 
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In addition to research activities, the institute has a diagnostic unit (IPATIMUP 
Diagnostics), whose mission is to provide excellent services in surgical pathology, 
cytopathology, molecular pathology and forensic genetics. This unit performs annually 
about 20.000 diagnostic tests, and was one of the first laboratories in the world to 
implement and validate the use of next generation sequencing in routine practice, being 
a reference partner for several companies in the pharmaceutical sector (e.g., Bayer, 
Abbvie, Astrazeneca). 
More recently, two new units were created, the innovation unit and the translational 
research unit. The mission of the innovation unit is to extract economic value of the 
knowledge generated by R&D activities of IPATIMUP and stimulate the creation of 
spin-off companies. The translational research unit has as main aims to raise external 
funds in the form of research contracted, and the integration of IPATIMUP into 
international networks of translation in oncology and strategic partnerships with 
industry, in order to reduce its dependence on the public funds in future.  
In addition, IPATIMUP was awarded, in 2014, by the Portuguese Pharmaceutical 
Industry Association (APIFARMA) “Best Research Partner” of the pharma industry, a 
prize that was attributed in the context of the celebration of the 75 years of 
APIFARMA. 
3.3. Data Collection 
Initially, we conducted one face-to-face interview
6
 with André Albergaria - Director of 
IPATIMUP Translational Research Unit, Jorge Lima – Vice – Director of IPATIMUP 
Translational Research Unit and Hugo Prazeres – Director of IPATIMUP Innovation 
Unit in order to understand what R&D projects with the industry can be subject of study 
in the present work.  
There was some difficulty finding feasible projects for the analysis, since most projects 
are partnerships with international industry and therefore protected by confidentiality. 
Nevertheless, it was suggested a project, still under development, named ‘Using NGS to 
uncover structural and regulatory variation in gastric cancer’. This project represents 
our unit of analysis. 
“This is the only project that we have that is national in the sense of being a Portuguese 
company and a Portuguese institute. This is not in fact the most common type of projects we 
                                                          
6
 Interview in February 27
th
, 2015, lasting one hour. 
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have; most are projects with international industry.” (André Albergaria, Researcher/ Director 
of IPATIMUP Translational Research Unit, Porto, February 27
th
, 2015) 
In the context of the project in analysis we conducted three interviews with key 
stakeholders in the process: Carla Oliveira,
7
 Principal Investigator and responsible for 
the scientific development of the project; André Albergaria,
8
 director of IPATIMUP 
Translational Research Unit and responsible for the implementation of the negotiation 
process with the company; and Nuno Arantes – Oliveira,9 CEO at the time of the 
interview and current chairman of the board of directors of Coimbra Genomics. 
We asked to respondents questions about how the project was initiated and what were 
the objectives. We also enquired about the type and frequency of meetings, the 
frequency of visits and other exchanges, and the nature and degree of interdependence 
of various participants. We asked the participants to describe how relationships with 
partners were established and whether they had experienced any problems or barriers, 
what were the rationales for their decisions to work with partners and what were the 
benefits from their viewpoint. Finally, we enquired them about the scientific outputs 
and IP terms.        
3.4. A description of the selected project  
Coimbra Genomics is a Portuguese start – up that was founded in 2013 by Critical 
Software, Biocant Park and a group of entrepreneurs and leading scientists in which 
benefited from an investment of venture capital funds, Portugal Ventures and Critical 
Ventures. The company’s main mission is to use genomic information to help clinicians 
make more personalized decisions. 
Coimbra Genomics when started its activity deemed it useful to have links to the major 
players of genomics worldwide and in this context contacted Beijing Genomics Institute 
(BGI) to see whether there would be any interest in joint projects. They referenced 
several projects that would be possible to develop in Portugal in various therapeutics 
and BGI showed much interest in stomach cancer area, since it is a disease with high 
prevalence, difficult to treat and currently with few treatment solutions and furthermore 
there are many unknowing about their genetic basis.  
                                                          
7
 Face – to – face interview in April 1st, 2015, lasting one hour. 
8
 Face – to – face interview in April 1st, 2015, lasting one hour. 
9
 Skype Interview in April 14
th
, 2015, lasting half an hour. 
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From there, Coimbra Genomics (CG) contacted the IPATIMUP to establish a 
partnership for this project. First, because it was considered by CG a renowned institute 
with excellent technical and scientific skills in the area. Second, because the CEO of the 
company knew the institute due to his previous professional experiences.  
Gastric cancers are highly heterogeneous and the therapy does not work in general. 
Currently, the only way to slow down the disease is to have a surgery, which is only 
efficient in individuals who are diagnosed at a very early stage. When the disease is in 
the later stages surgery slows the disease but does not cure. Thus it would be very 
important to find a way to stratify patients with gastric cancer in order to give them 
more efficient and personalised therapies.  
This project aims mainly to collect a number of cases of gastric cancer from tumour and 
tissues bank, confirm that they have cancer and then try to optimize a pre-stratification 
strategy. What has happened so far is that people have studied the gastric cancer and 
made the genome of cancer, took up series completely at random, with great 
heterogeneity and small numbers which does not allow to find relevant factors.  
IPATIMUP tried to combat this categorizing and pre-stratifying cases into groups, more 
specifically, in three groups considered relevant from genetic and molecular point of 
view, and then submit them to the sequencing. The aim was to understand whether in 
each of these groups, in addition to the pre-stratified that allow them to separate, they 
maintain a ‘signature’ which made them eligible for a particular therapy. 
So, the goal of IPATIMUP, as the scientific project leader, was to choose the series 
based on its knowledge of gastric cancer, find pre-stratifiers, pre-stratify and send 
genetic material to BGI to do the sequencing. After BGI send back the data, the next 
step is to analyse the bioinformatics view all information, integrate it and then try to 
extract the potential markers that can identify the type of specific therapy for each of 
those groups. 
The advantage of this is that if one really finds something that is characteristic for each 
group, it won’t be necessary sequencing every time it appears in a patient in the 
hospital. That patient will be routed to the most appropriate therapy to the case.  
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4. Impact of corporate R&D on IPATIMUP’s scientific performance. An analysis 
of the results according to the theoretical framework 
4.1. Determinants of the outputs 
4.1.1. Context 
According to the literature, university – industry partnerships are a key strategic pillar 
for innovation of a country or region. However, in the Portuguese context these 
partnerships still a challenge that is far from being overpassed. Some studies (e.g., 
Teixeira and Costa, 2006; OECD, 2013) have shown that in Portugal the links between 
companies and universities reflect some shortage and lack of sustainability compared 
with other OECD countries. 
Aimed at promoting and boosting the scientific and technological system in order to 
make it more competitive and streamline the relationship between knowledge centers 
and enterprises, in the most recent National Strategic and Reference Board (QREN), it 
were established instruments to encourage such cooperation, where access to finance for 
certain projects have a mandatory requirement, the involvement of the business sector 
(Comissão Técnica de Coordenação do QREN, 2013).  
Although there is little dynamics in U-I interaction in Portugal, according to the annual 
evaluation report of QREN (Comissão Técnica de Coordenação do QREN, 2013: 61), 
until the end of 2012, it was contracted 76 projects of cooperation between companies 
and research institutions, being biotechnology the scientific area with the second largest 
number of cooperation projects (13% of the total approved projects), after ICT area 
(19% of the approved projects) (Comissão Técnica de Coordenação do QREN, 2013:  
136). 
Institutionally, the area of genomics is very specialized and intensive in highly 
advanced scientific knowledge, consisting of a small number of players (Dalpé, 2003). 
So, tacit and informal knowledge plays a key role making the U-I partnerships very 
relevant in the process (Dalpé, 2003). 
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4.1.2. University – Organizational and Individual Factors 
Project Management 
The IPATIMUP is an institute with 26 years of existence, and in terms of organizational 
structure is well established and divided by departments. 
With recent budget cuts allocated to science, IPATIMUP felt the need to create, in 
2012, a unit with the objectives of rising external funds and establishing strategic 
partnerships with industry looking in that way lessen its dependence on the national 
foundation for science (FCT), the main Portuguese science funding body. The 
IPATIMUP Translational Research unit serves as an interface between research groups 
and their industrial partners. 
“Within the institute we have the translational unit that help us get the project standing, 
negotiated with Coimbra Genomics, and this is really good for us.” (Carla Oliveira, Project's 
Principal Investigator of IPATIMUP, Porto, April 1
st
, 2015).  
“Our role is to coordinate the whole process and control it from the beginning to the end.” 
(André Albergaria, Researcher/ Director of IPATIMUP Translational Research Unit, Porto, April 
1
st
, 2015). 
This project provided another partnership with industry, one additional experience for 
the unit, thereby enhancing the project management’s skills, permitting to apply that 
knowledge for the benefit of future partnerships. 
Department quality 
As mentioned above, the IPATIMUP is a laboratory with 26 years and during that time 
was asserting its scientific excellence and its expertise in the area of cancer, deserving 
the national and international recognition. This is was a decisive factor for the 
establishment of partnerships with industry both at national (Coimbra Genomics) and 
international level (Beijing Genomics Institute). 
“This project arose from our desire to work with Beijing Genomics Institute, of gastric cancer is 
an area of particular interest because it has a high prevalence both in China and Portugal and 
there is a technical and scientific capacity in Portugal, in particular in IPATIMUP, which is 
excellent, the best even international level.” (Nuno Arantes – Oliveira, CEO of Coimbra 
Genomics at the time of the interview, Skype interview, April 14
th
, 2015).    
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Team Experience/ Reputation 
All the scientific part of the project was structured and is being developed by 
IPATIMUP, which has as its Principal Investigator (PI) Carla Oliveira.  
Carla Oliveira,
10
 as most researchers of the institute, has a very robust curriculum in 
terms of scientific publications in the area (more than 80 publications).
11
 She has 
experience in similar projects and in parallel to this project she is principal investigator 
of other research projects in gastric cancer. She has a PhD degree in Human Biology by 
Medical Faculty of Porto, and a Post Doc in Pathology by British Columbia University 
(Vancouver, Canada), in which she collected an award of Patient Organization ‘No 
stomach for cancer’.12 Currently she leads the research group ‘Expression regulation in 
cancer’ responsible for developing the project under study and is Associate Professor of 
Biopathology in Medical Faculty of University of Porto. 
Besides Carla Oliveira (PI), 7 researchers are part of the research team of the project: 
Ana Sofia Varanda, PhD student; Ana Valente, Research Trainee; Gabriela Almeida, 
she also experienced in the area of gastric cancer in which is principal investigator of 
another similar project (‘Improving gastric cancer patient stratification towards 
personalised therapy’); Hugo Pinheiro, Post Doc student; Joana Carvalho, Post Doc 
student with experience in other gastric cancer projects; Patrícia Oliveira, Post Doc 
student also with experience in gastric cancer and in addition has advanced knowledge 
in Bioinformatics; and Sara Rocha, Research Trainee. 
4.1.3. Corporate/Industry - Individual and Organizational Factors  
Project Management 
As mentioned above, Coimbra Genomics is a company founded recently, so still is an 
embryonic state. Then, we can say that it is an organization that is characterized by a 
single-celled structure. 
                                                          
10
 https://www.ipatimup.pt/ site/PersonView.aspx?IsPrintable = True&PersonId= 35&OrgUnitId=0, 
accessed in June 29
th
, 2015 
11
http://www.scopus.com/results/results.url?sort=plf-f&src=s&st1=Oliveira&st2=Carla&nlo= 1&nlr= 20 
&nls=count-f&sid=8C0A7415417A4AB11CBF05BB5C7A3C28.WlW7NKKC52nn QNxjqAQrlA%3a63 
&sot=anl&sdt=aut&sl=35&s=AU-ID%28%22Olive%C3%ADra%2c+Carla%22 +7102223149%29& 
txGid=8C0A7415417A4AB11CBF05BB5C7A3C28.WlW7NKKC52nnQNxjqAQrlA%3a6, accessed in 
June 29
th
, 2015  
12
 http://www.cienciahoje.pt/index.php?oid=58794&op=all, accessed in June 29
th
, 2015 
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Thus, the entire business process is mostly led by two scientists - Nuno Arantes – 
Oliveira and Bruno Soares. This can confer some degree of flexibility in implementing 
the partnership process.  
“This process was all a very close process between the unit, the institute and the company. So no 
two teams here working, there was rather a team of researchers, with some of them more focused 
on project management and others more focused on the scientific thought, the scientific input in its 
strategic way.” (André Albergaria, Researcher/ Director of IPATIMUP Translational Research 
Unit, Porto, April 1
st
, 2015) 
In this case, the project is funding by Coimbra Genomics and thus the entire 
management of the logistic process is the responsibility of the firm. 
“We rely on the Coimbra Genomics for all negotiations with Beijing Genomics Institute, and this 
is a plus because these projects that I have direct funding, most of the time I have not only to write 
them but also manage them from the administrative and financial point of view. Here I am 
completely free of it, the whole logistic process is managed by the company.” (Carla Oliveira, 
Project's Principal Investigator of IPATIMUP, April 1
st
, 2015).  
“In practical terms what we do is to coordinate the project, manage, subcontracted the Beijing 
Genomics Institute - the IPATIMUP performs the technical and scientific part.” (Nuno Arantes – 
Oliveira, CEO of Coimbra Genomics at the time of the interview, Skype Interview, April 14
th
, 
2015). 
 
Department quality/ Team Experience 
Coimbra Genomics combines the business knowledge of investors and external 
consultants from several areas– with individuals - Nuno Arantes – Oliveira and Bruno 
Soares - with a strong scientific knowledge in the area and a considerable 
entrepreneurial background. These latter individuals were able to identify a market need 
that led to the emergence of this start-up and therefore the project under study.  
Bruno Soares, current CEO of Coimbra Genomics, has an extensive scientific, 
technological and business experience in the field of biochemistry and DNA 
sequencing, having been ‘Chief Scientific Officer' of a start-up also in the genomics 
area, Base4,
13
 and has been involved in the creation of the nanophotonic center at the 
University of Cambridge.
14
  
                                                          
13
https://www.ipo.gov.uk/types/patent/p-os/p-journal/p-pj/p-pj-
ukapppub?lastResult=60&perPage=10&startYear=2013&startMonth=June&startDay=26th+-+6475&end 
Year=2013&endMonth=June&endDay=26th+-+6475&filter=&sort=Publication+ Date&status=undefined 
accessed in June 22
th
, 2015  
14
 http://www.np.phy.cam.ac.uk/people/alumni, accessed in June 22
th
, 2015  
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Nuno Arantes – Oliveira15 holds a PhD in Genetics, has a very strong curriculum in 
terms of publications, some of them in the prestigious journal Science.
16
 He founded 
several companies in Europe and United States, including the Alfama Inc.,
17
 a biotech 
company dedicated to the development of a new class of drugs based on controlled 
release of carbon monoxide in specific organs and tissues and also led Portugal's 
Biotechnology Industry Organization (P-BIO)
18
 between 2011 and 2015. 
As is clear these two scientists have extensive experience both in scientific research and 
in their entrepreneurial capacity, which is internationally recognized. This is important 
because on the one hand it permits to establish contacts with major players in the area 
worldwide and on the other guarantees important scientific inputs into the development 
of the project. 
4.2. U-I interactions 
Relations between different types of organizations, including public R&D institutes and 
private companies that have characteristics, cultures and different perspectives often 
result in conflicts and that can be a barrier to partnership (Harris and Lyon, 2013).  
In this project one of the difficulties mentioned by all stakeholders interviewed was the 
negotiation process. 
“The first barrier was soon in contract negotiations because we do not speak the same language. 
There have been many meetings to reach an agreement that is ideal for all.” (Carla Oliveira, 
Project's Principal Investigator of IPATIMUP, Porto, April 1
st
, 2015). 
“The project with the Coimbra Genomics had no trouble beyond those hits that are normal to be 
discussed, is a business, there are always different opinions, there is always a need to sit at the 
table again... Usually, the projects that give rise to contracts and the discussion of these contracts, 
the most obvious points that have to be clarified relate to intellectual property issues, how this is 
managed, which side is which, etc.” (André Albergaria, Research/ Director of IPATIMUP 
Translational Research Unit, Porto, April 1
st
, 2015).   
“In the negotiation process there are always advances and retreats, it is normal one party asking for 
something that the other thinks it is not right, but that is part of the negotiation.” (Nuno Arantes – 
Oliveira, CEO of Coimbra Genomics at the time of the interview, Skype Interview, April 1
st
, 2015) 
                                                          
15
 http://healthportugal.com/noticias/iihcpconf/nuno-arantes-oliveira, accessed in June 22
th
, 2015.  
16
http://www.scopus.com/results/results.url?sort=plf-f&src=s&st1=Arantes+Oliveira&st2=Nuno&nlo = 1 
&nlr =20&nls=count-f&sid=EE4396DBDC40D8451219 CBFDD1B27BCB.fM4v PBipdL1Bpir Dq5Cw 
%3a93&sot =anl&sdt=aut&sl=42&s=AU-ID%28%22Arantes-Oliveira %2c+Nuno %22+ 6507120885 
%29&txGid=EE4396DBDC40D8451219CBFDD1B27BCB.fM4vPBipdL1 BpirDq5Cw%3a9, accessed 
in June 29
th
, 2015 
17
 http://www.healthportugal-directory.com/pt/membership-directory/alfama-inc, accessed in June 22
th
, 
2015.  
18
http://www.atlasdasaude.pt/publico/content/p-bio-reforcada-elege-nova-direcao-com-os-olhos-no-futuro 
-da-inovacao-em-portugal, accessed in June 22
th
, 2015. 
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In order to mitigate these barriers/ conflicts this partnerships was sustained on the basis 
of trust that exists between partners developed by previous professional experiences, 
since Nuno Arantes – Oliveira is external consultant of IPATIMUP’s Translational 
Research Unit and IPATIMUP’s Innovation Unit. In addition, and as previously 
mentioned, the area of genomics/ life sciences is very intensive in knowledge and 
characterized by a small number of players, which in turn can lead to a certain closeness 
between them, making the collaborative process more flexible and effective. 
“Coimbra Genomics participate in scientific discussion. Every time we decide on a strategy, 
this strategy is discussed with the company because they are also scientists...The division of 
labour has been versatile enough for us to manipulate the collaboration of each. As we are 
working on the same project turns out to be cooperative.” (Carla Oliveira, Project's Principal 
Investigator of IPATIMUP, Porto, April 1
st
, 2015). 
4.3. Ongoing outputs of the project 
4.3.1. Learning opportunities/New projects 
Although the project is not yet finalized, for IPATIMUP it has created up to the present 
date the possibility of obtaining tumour data providing therefore support to research in 
the upcoming years. Additionally, it provided the IPATIMUP the possibility of creating 
a relationship of trust with a company encouraging other consortium projects and 
(eventually) by companies. 
“This opened up the possibility of entering in a series of partnerships with Coimbra Genomics 
that will allow us to compete in Europe, because we have created a degree of enormous trust 
with them and them with us.” (Carla Oliveira, Project's Principal Investigator of IPATIMUP, 
Porto, April 1
st
, 2015). 
For Coimbra Genomics to work with IPATIMUP and Beijing Genomics Institute 
allowed the access to samples and clinical cases that are not very common. In a more 
strategic approach, has enable them to establish relations of trust and trade relations 
with important players in the field of genomics, enhancing future collaborations and 
sources of ideas/ knowledge potentially valued by the market. 
4.3.2. Publications 
The IPATIMUP retains the right to scientifically explore, in exclusive terms, the project 
results through publications.  
“All that is results for scientific exploration is on our side.” (André Albergaria, 
Research/Director of IPATIMUP Translational Research Unit, Porto, 1 April 1
st
, 2015). 
 27 
“We are the sponsor of the project, and the intellectual property that results from the project is 
ours. Under an agreement that we made with Beijing Genomics Institute, this IP is shared to 
some extent with them but the ownership of the IP is ours. IPATIMUP grants the possibility to 
publish, that is, there is a certain freedom of the IPATIMUP to use the results to its scientific or 
academic advantage.” (Nuno Arantes – Oliveira, CEO of Coimbra Genomics at the time of the 
interview, Skype Interview, April 14
th
, 2015) 
4.3.3. New knowledge/ Patents 
It is expected that from the project it will result proprietary knowledge about genetic 
biomarkers, which indicate potential therapeutic targets for gastric cancer (e.g. genetic 
variations that are the cause of gastric cancer and that can be the target for new 
therapies).  
In this context, the idea of Coimbra Genomics is to protect such knowledge through 
Intellectual Property (IP), namely through patents, that are able to be marketable, 
creating new products and/or processes. 
“For Coimbra Genomics [the project] has opened the possibility to creating new intellectual 
property in an area that has scientific, medical, social and commercial value.” (Nuno Arantes – 
Oliveira, CEO of Coimbra Genomics at the time of the interview, Skype Interview, April 14
th
, 
2015). 
Importantly, scientific knowledge and commercial character that results from this 
cooperation will tend to influence the interrelation process of the various players. In 
concrete, it allows IPATIMUP to optimize the scientific process in the genomics area, 
adding to its already vast scientific knowledge more applied procedures directed to the 
market opportunities satisfaction.  
“Here the needs that have been raised by Coimbra Genomics made that the research group to 
think objectively to respond to such need... This is a good example that corporate's needs change 
the way we think and urged us to find out how to address that problem. There is a clear paradigm 
shift within the academia, within IPATIMUP from the moment we open doors to industry.” 
(André Albergaria, Researcher/ Director of IPATIMUP Translational Research Unit, Porto, April 
1
st
, 2015)  
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5. Conclusions  
5.1. Main results and contribution of the study (vis a vis other similar studies) 
In this dissertation we aimed to understand how corporate R&D and/or corporate’s 
needs impacted on academic research performance, which has not yet been sufficiently 
investigated in the literature. 
Through a qualitative analysis, it was demonstrated that collaboration between 
IPATIMUP and Coimbra Genomics resulted in a win-win relationship. Additionally, 
evidence was gathered that the corporate R&D has been critical in influencing 
IPATIMUP’s performance in terms of procedures, learning opportunities and 
capabilities to promote more and better innovative research.  
In this context, several critical factors have mediated the relation between corporate 
R&D and the research performance of IPATIMUP. The scientific discipline (Life 
Sciences/ Biotechnology) and the industry characteristics (highly advanced scientific 
knowledge, small number of players, and a very limited diffusion of knowledge) played 
an important role in the formation of the collaborative relationship. Indeed, the area of 
biotechnology is very specialized and intensive in advanced knowledge, being therefore 
highly dependent on academic research/scientific breakthroughs. Knowledge proximity 
and trust (based on previous shared professional experiences) existent between 
corporate and academic players overcame issues related to geographical distance (Porto-
Coimbra-China). 
Extant literature (Schartinger et al., 2002; Dalpé, 2003; Barbolla and Corredera, 2009; 
Perkmann et al., 2012) evidenced that the most experienced and highly renowned 
researchers were more likely to engage with industry and thus are key determinants for 
the success of the partnership and its outcomes. The present case study highlights that 
both academic and corporate researchers had substantial experience in the genomic area, 
reflected by the fact that they possessed doctoral degrees granted by international well 
renowned schools and by the quantity and quality of their scientific publications. 
Moreover, actors in the process shared previous professional experiences, which 
enhanced trust and therefore facilitated the process of establishment and development of 
the project.  
It is argued that the diversity of teams, combining researchers with different age, gender 
and areas of expertise, tend to stimulate creativity (Bear and Woolley, 2011; Pitt-
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Catsouphes et al.; 2013; Lee et al., 2015). In the present study, and according the 
interviews, no evidence was produced that the composition of researchers’ age or 
gender was crucial to the development of the project. However, the combination in a 
same team of individuals with distinct expertise - knowledge of life sciences and basic 
research by IPATIMUP’s researchers and the technological expertise associated to more 
applied research by firm’s collaborators - was critical for the outputs of the project, 
namely the development of a new product.  
The evidence gathered in the present study supports the idea of Schartinger et al. (2002) 
and King et al. (2011) that department quality is one of the most important factors 
considered by industry when establishing partnerships with universities. Indeed, 
Coimbra Genomics highlighted this factor as crucial to establish the partnership with 
IPATIMUP. Furthermore, and in line with previous studies (Butcher and Jeffrey, 2007; 
Thune, 2011), project management was a key element for the success of the 
collaboration. Establishing common expectations and objectives and building a trust–
based relationship have been essential in overcoming hurdles derived from different 
cultures and perspectives of the two types of organizations (academic and corporate). 
5.2. Implications for public policy authorities 
In terms of policy implications, our findings suggest that policy makers should place 
greater emphasis on creating effective policies to promote university – industry 
cooperation network due to several reasons. 
First, scientific knowledge and commercial character that resulted from this cooperation 
allowed IPATIMUP to optimize the scientific process in order to respond to market’s 
needs and making more applied research. Notwithstanding, some authors (e.g. Lacetera, 
2009; Perkmann and Walsh, 2009; Fuentes and Dutrénit, 2012) have criticized the 
potentially detractive effects of such ‘entrepreneurial’ science on the long-term 
production of scientific knowledge. These authors fear that academic science is being 
instrumentalized and even manipulated by industry and they listed several risks, such as 
reduction in academic freedom, the slow-down of open knowledge diffusion and lower 
levels of research productivity among academics. In this context, in order to 
maximizing the benefits of academic research, it is relevant the development of policies 
that increased interaction between academia and firms while protecting the autonomy 
and freedom of researchers.  
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Second, and as mentioned earlier, the area of biotechnology is very specialized and 
intensive in advanced knowledge, being therefore highly dependent on academic 
research. Thus, the development of biotech is certainly one of the greatest examples of 
the social benefits that might be derived from investments in science.  
Third, in times of economic recession and state budget constraints dedicated to public 
R&D, this type of collaboration allows public research institutes/ university to obtain 
additional financing for research and financing for students in their master and doctoral 
thesis. 
5.3. Limitations of the study and avenues for future research 
This work has some noteworthy limitations. In order to extract detailed information on 
the characteristics of collaboration, our analysis was carried out using an single project 
level data collected from interviews and, necessarily relies on a small sample of 
observations. In addition, this is an on-going project which did not permit to have a 
full/comprehensive picture of the project’s outcomes. So, further research is needed to 
expand the size of the sample and include several case studies (preferably projects 
already completed and with longer time horizon) in order to compare their 
characteristics. 
Another limitation is that our research focused on university – industry collaboration 
within the life sciences/ biotechnology disciplines that are traditionally far to industrial 
application. In this context, future research should explore to what degree our 
considerations apply to other research fields, such as the engineering and chemistry 
have also traditionally been strongly linked with industrial application. Moreover, our 
analysis focused only one type of interaction between university and industry – contract 
research. So, further research should examine other types of interaction like 
collaborative research (where there is a division of scientific labour between partners) 
and/or consulting, in order to understand the differences. 
Finally, this is a single country study. It would be interesting to analyse the extent to 
which these results can be generalized to other countries given that cross-country 
differences may exist specific academic, industrial and political contexts.   
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